Facial Plast Surg 2009; 25(2): 067-072
DOI: 10.1055/s-0029-1220645
© Thieme Medical Publishers

The History of Injectable Facial Fillers

Theda C. Kontis1 , Alexander Rivkin2
  • 1Assistant Professor, Johns Hopkins Medical Institutions, Baltimore, Maryland
  • 2UCLA David Geffen School of Medicine, Los Angeles, California
Further Information

Publication History

Publication Date:
04 May 2009 (online)

ABSTRACT

In an attempt to maintain a youthful appearance or to reconstruct facial deformities, physicians have greeted new technologies with excitement. In the late 1800s, shortly after the invention of the syringe, chemical agents were used for facial augmentation. Unfortunately, history has taught us that new technologies must be used with care, because complications can occur, sometimes many years after initial treatment. The first injectable filling agent was paraffin, whose use was abandoned after complications of migration, embolization, and granuloma formation were described. More recently, silicone use was banned by the U.S. Food and Drug Administration (FDA) because of similar complications. In 1981, bovine collagen was the first agent to be approved by the FDA for cosmetic injection. Since its approval, dozens of injectable filling agents have been developed, and many are already FDA approved for cosmetic use. This article will review the highlights of the evolution of facial filling agents.

REFERENCES

  • 1 Murray C A, Zloty D, Warshawski L. The evolution of soft tissue fillers in clinical practice.  Dermatol Clin. 2005;  23 343-363
  • 2 Feldmann H. History of injections. Pictures from the history of otorhinolaryngology highlighted by exhibits of the German History of Medicine Museum in Ingolstadt.  Laryngorhinootologie. 2000;  79 239-246
  • 3 Goldwyn R M. The paraffin story.  Plast Reconstr Surg. 1980;  65 517-524
  • 4 Glicenstein J. The first “fillers,” Vaseline and paraffin: from miracle to disaster [in French].  Ann Chir Plast Esthet. 2007;  52 157-161
  • 5 Uchida Y, Yoshii N, Kubo H et al.. Facial paraffinoma after cosmetic paraffin injection.  J Dermatol. 2007;  34 798-800
  • 6 Di Benedetto G, Pierangeli M, Scalise A, Bertani A. Paraffin oil injection in the body: an obsolete and destructive procedure.  Ann Plast Surg. 2002;  49 391-396
  • 7 Dastoor S F, Misch C E, Wang H-L. Dermal fillers for facial soft tissue augmentation.  J Oral Implantol. 2007;  33 191-204
  • 8 Klein A W. Techniques for soft tissue augmentation.  Am J Clin Dermatol. 2006;  7 107-120
  • 9 Chasan P E. The history of injectable silicone fluids for soft-tissue augmentation.  Plast Reconstr Surg. 2007;  120 2034-2040
  • 10 Humble G, Mest D. Soft tissue augmentation using silicone: an historical review.  Facial Plast Surg. 2004;  20 181-184
  • 11 Ficarra G, Mosqueda-Taylor A, Carlos R. Silicone granuloma of the facial tissues: a report of seven cases.  Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;  94 65-73
  • 12 Murray C A, Zloty D, Warshawski L. The evolution of soft tissue fillers in clinical practice.  Dermatol Clin. 2005;  23 343-363
  • 13 U.S. FDA .http://Available at: www.fda.gov/cdrh/devadvice/312.html Is the product a medical device?. Accessed 10/22/2008
  • 14 U.S. House of Representatives .Report 102–1064. Is the FDA protecting consumers from dangerous off-label uses of medical drugs and devices?. November 19, 1992 Washington, DC; U.S. House of Representatives
  • 15 Fagien S, Klein A W. A brief overview and history of temoprary fillers: evolution, advantages, and limitations.  Plast Reconstr Surg. 2007;  120(Suppl) 8S-16S

Theda C KontisM.D. F.A.C.S. 

Facial Plastic Surgicenter, 1838 Greene Tree Road

Suite 370, Baltimore, MD 21208

Email: tckontis@aol.com

    >